회사 소개
Raising CRO standards for innovation and delivery to help bring life-changing treatments to patients faster.
Fortrea Origins
Get to know us all over again. With a new name and a fresh look at the CRO industry—fueled by a legacy of product development expertise—we are raising CRO standards.
A legacy of innovation
Our story … starting with today
As one of the first CROs, we have a long heritage of product development. Beyond executing studies for our customers, our history reflects our commitment to innovate as we continually seek new ways to improve and enhance the drug development process.
2024
Fortrea focuses on core CRO services and value creation by spinning off FortreaRx™, patient access services and Endpoint Clinical
2023
Fortrea spins off from Labcorp to focus on being the leading clinical services provider
2021
Covance changes name to Labcorp Drug Development
2020
Acquisition of technology to support decentralized clinical trials
2020
Acquisition of remote nursing offering
2019
Covance acquires RCRI, entering the MedTech market
2018
Acquisition of pharmacovigilance capabilities
2017
Covance acquires Chiltern, enhancing biotech expertise
2017
Covance acquires Endpoint Clinical, adding IRT and clinical supply management solutions
2015
Covance joins Labcorp, connecting research and diagnostics
2014
Acquisition of market access consulting
1997
Corning spins off Covance as a publicly traded company, forming one of the first CROs
1990s
Corning Incorporated acquires numerous best-of-class drug development companies
Evolving over 30 years
Raising CRO standards
We’re shattering existing assumptions, creating solutions that drive faster decision-making and innovating at the speed of change.
Agility at scale
Scaled to manage risk and navigating complexities with agility
Insight and experience
Insight-driven expertise to unlock what's possible
Audience-focused
Anticipating expectations, transparent collaboration, exceptional partnerships
Our First CSR Report.
Fortrea for Better.
Fortrea’s ability to deliver our mission relies on trust. Employee trust, customer trust, patient trust. Shareholder trust. Trust of the communities where we work. Trust is built day to day, based on what we do and how we do it. Read our inaugural Corporate Social Responsibility Report to learn about many of the environmental, social and governance (ESG) activities we’ve undertaken to cultivate in our first year as an independent company.
Our vision
Powering customers to achieve their aspirations with innovation that combines the best people, science and technology.
Culture
We deliver through our culture—for customers, trial participants and sites. Partnering together, we approach our work with respect for one another and accountability to always do the right thing in the right way.
리더십
With a wealth of insights, our leadership is leading the way as we raise CRO standards. They are driving innovation and agility with a focus on helping sponsors bring treatments to patients faster.
위치
From diversity of patients to the geographic spread of markets, clinical trials are global. We have the global reach to provide local insights—ranging from regulatory details to standards of care and local practices—to ensure your study meets the demand of a global market.
Quality
Our commitment is quality, and our entire organization is geared to ensure it. Whether it’s meeting a sponsor’s standard, a regulatory requirement or an internal benchmark, our culture and our team are focused on getting it right—the first time.
Our experts
Expertise matters. With a deep team of clinical, scientific, medical, operational and technical talent, our team delivers insights that help you traverse the product development process.
We put patients at the center of everything we do. Whether we’re conducting a large-scale global clinical trial or a small, intensive proof-of-concept study, we’re working with the endpoint in mind—getting better, more effective treatment options to the patients who need them.
Chief Medical Officer, Fortrea
We put patients at the center of everything we do.